Marshall, I; Thrippleton, MJ; Bastin, ME; Mollison, D; Dickie, DA; Chappell, FM; Semple, SIK; ... Chandran, S; + view all Marshall, I; Thrippleton, MJ; Bastin, ME; Mollison, D; Dickie, DA; Chappell, FM; Semple, SIK; Cooper, A; Pavitt, S; Giovannoni, G; Wheeler-Kingshott, CAMG; Solanky, BS; Weir, CJ; Stallard, N; Hawkins, C; Sharrack, B; Chataway, J; Connick, P; Chandran, S; - view fewer (2018) Characterisation of tissue-type metabolic content in secondary progressive multiple sclerosis: a magnetic resonance spectroscopic imaging study. Journal of Neurology , 265 (8) pp. 1795-1802. 10.1007/s00415-018-8903-y.

Preview

Text Chataway_Characterisation of tissue-type metabolic content in secondary progressive multiple sclerosis. A magnetic resonance spectroscopic imaging study_VoR.pdf - Published Version Download (2MB) | Preview

Abstract

Proton magnetic resonance spectroscopy yields metabolic information and has proved to be a useful addition to structural imaging in neurological diseases. We applied short-echo time Spectroscopic Imaging in a cohort of 42 patients with secondary progressive multiple sclerosis (SPMS). Linear modelling with respect to brain tissue type yielded metabolite levels that were significantly different in white matter lesions compared with normal-appearing white matter, suggestive of higher myelin turnover (higher choline), higher metabolic rate (higher creatine) and increased glial activity (higher myo-inositol) within the lesions. These findings suggest that the lesions have ongoing cellular activity that is not consistent with the usual assumption of ‘chronic’ lesions in SPMS, and may represent a target for repair therapies.

Download activity - last month

Export as CSVJSONXML

Download activity - last 12 months

Export as XMLCSVJSON

Downloads by country - last 12 months

Export as XMLJSONCSV

Archive Staff Only

View Item